FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W252275679> ?p ?o ?g. }

• W252275679 abstract "Diabetes mellitus is one of the leading causes of illness and death in North America. Cardiovascular diseases are a common secondary complication in the diabetic population. One of the important risk factors identified for the development of cardiovascular disease is an elevation in the sulfur amino acid, homocysteine. Although the exact mechanism(s) that underlie the relationship between elevated plasma homocysteine levels and cardiovascular disease remain unclear, it has been suggested that endothelial dysfunction produced by modestly elevated blood homocysteine concentrations may account for an increased risk of both arterial and venous occlusive disease.The present study examined the effects of three- and eight-weeks bis(maltolato)oxovanadium(IV) (BMOV) treatment on plasma concentrations of homocysteine and cysteine in both control and streptozotocin (STZ) diabetic rats.Diabetes was induced in male Wistar rats by a single intravenous injection of STZ (60 mg/kg) in normal saline. Control animals received normal saline only. Animals were further randomized into treated and untreated groups. Treated animals received BMOV orally, dissolved in tap water, while untreated animals only received tap water. Three or eight weeks postinduction of diabetes, blood samples were obtained by cardiac puncture from the animals. Plasma harvested from each blood sample was used to determine glucose, insulin, homocysteine and cysteine concentrations.There was a significant decrease in plasma homocysteine levels in the diabetic (three- and eight-week study) groups compared with their respective controls (three-week study: diabetic group 3.1+/-0.7 mumol/L and control group 6.1+/-0.7 mumol/L; eight-week study: diabetic group 4.3+/-0.5 mumol/L and control group 6.9+/-1.0 mumol/L). Plasma cysteine levels were significantly decreased in the diabetic and diabetic treated groups (eight-week study) compared with their respective control groups (diabetic group 90.2+/-32.3 mumol/L and control group 177.9+/-36.7 mumol/L). BMOV treatment restored plasma homocysteine concentrations in diabetic animals to concentrations found in nondiabetic animals.Taken together, these findings suggest that STZ-induced diabetes may result in decreased plasma homocysteine and cysteine levels and that BMOV treatment may increase plasma homocysteine concentrations to nondiabetic concentrations. These results may provide further insight on how this insulin-enhancing/mimetic agent modifies plasma homocysteine metabolism." @default.
• W252275679 created "2016-06-24" @default.
• W252275679 creator A5007086008 @default.
• W252275679 creator A5066917876 @default.
• W252275679 creator A5072140726 @default.
• W252275679 creator A5077588116 @default.
• W252275679 creator A5089512236 @default.
• W252275679 date "2004-01-01" @default.
• W252275679 modified "2023-09-23" @default.
• W252275679 title "Effects of three and eight weeks oral administration of bis(maltolato)oxovanadium(IV) on plasma homocysteine and cysteine levels in streptozotocin-induced diabetic rats." @default.
• W252275679 cites W1511655466 @default.
• W252275679 cites W1964583223 @default.
• W252275679 cites W1965029028 @default.
• W252275679 cites W1969800712 @default.
• W252275679 cites W1988041601 @default.
• W252275679 cites W1991391165 @default.
• W252275679 cites W1994564997 @default.
• W252275679 cites W1995931698 @default.
• W252275679 cites W2001421142 @default.
• W252275679 cites W2020902432 @default.
• W252275679 cites W2028620758 @default.
• W252275679 cites W2032108914 @default.
• W252275679 cites W2039707682 @default.
• W252275679 cites W2044766431 @default.
• W252275679 cites W2052774348 @default.
• W252275679 cites W2062741774 @default.
• W252275679 cites W2068653999 @default.
• W252275679 cites W2069975826 @default.
• W252275679 cites W2074673535 @default.
• W252275679 cites W2078647607 @default.
• W252275679 cites W2086465198 @default.
• W252275679 cites W2110807383 @default.
• W252275679 cites W2111716072 @default.
• W252275679 cites W2118839146 @default.
• W252275679 cites W2128201389 @default.
• W252275679 cites W2128300830 @default.
• W252275679 cites W2137394317 @default.
• W252275679 cites W2147464835 @default.
• W252275679 cites W2152314194 @default.
• W252275679 cites W2158424537 @default.
• W252275679 cites W2163067510 @default.
• W252275679 cites W2164721380 @default.
• W252275679 cites W2165884492 @default.
• W252275679 cites W2166235806 @default.
• W252275679 cites W2166878032 @default.
• W252275679 cites W2268729060 @default.
• W252275679 cites W2415778146 @default.
• W252275679 cites W2471313104 @default.
• W252275679 cites W2471598710 @default.
• W252275679 cites W2975364463 @default.
• W252275679 cites W697503 @default.
• W252275679 cites W77188353 @default.
• W252275679 cites W90081202 @default.
• W252275679 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2716266" @default.
• W252275679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19641699" @default.
• W252275679 hasPublicationYear "2004" @default.
• W252275679 type Work @default.
• W252275679 sameAs 252275679 @default.
• W252275679 citedByCount "1" @default.
• W252275679 countsByYear W2522756792020 @default.
• W252275679 crossrefType "journal-article" @default.
• W252275679 hasAuthorship W252275679A5007086008 @default.
• W252275679 hasAuthorship W252275679A5066917876 @default.
• W252275679 hasAuthorship W252275679A5072140726 @default.
• W252275679 hasAuthorship W252275679A5077588116 @default.
• W252275679 hasAuthorship W252275679A5089512236 @default.
• W252275679 hasConcept C126322002 @default.
• W252275679 hasConcept C134018914 @default.
• W252275679 hasConcept C164705383 @default.
• W252275679 hasConcept C16525657 @default.
• W252275679 hasConcept C185592680 @default.
• W252275679 hasConcept C2776553924 @default.
• W252275679 hasConcept C2777090595 @default.
• W252275679 hasConcept C2777466421 @default.
• W252275679 hasConcept C2778198053 @default.
• W252275679 hasConcept C2778797674 @default.
• W252275679 hasConcept C2779134260 @default.
• W252275679 hasConcept C2779375456 @default.
• W252275679 hasConcept C2780074459 @default.
• W252275679 hasConcept C2780912031 @default.
• W252275679 hasConcept C515207424 @default.
• W252275679 hasConcept C55493867 @default.
• W252275679 hasConcept C555293320 @default.
• W252275679 hasConcept C71924100 @default.
• W252275679 hasConceptScore W252275679C126322002 @default.
• W252275679 hasConceptScore W252275679C134018914 @default.
• W252275679 hasConceptScore W252275679C164705383 @default.
• W252275679 hasConceptScore W252275679C16525657 @default.
• W252275679 hasConceptScore W252275679C185592680 @default.
• W252275679 hasConceptScore W252275679C2776553924 @default.
• W252275679 hasConceptScore W252275679C2777090595 @default.
• W252275679 hasConceptScore W252275679C2777466421 @default.
• W252275679 hasConceptScore W252275679C2778198053 @default.
• W252275679 hasConceptScore W252275679C2778797674 @default.
• W252275679 hasConceptScore W252275679C2779134260 @default.
• W252275679 hasConceptScore W252275679C2779375456 @default.
• W252275679 hasConceptScore W252275679C2780074459 @default.
• W252275679 hasConceptScore W252275679C2780912031 @default.
• W252275679 hasConceptScore W252275679C515207424 @default.
• W252275679 hasConceptScore W252275679C55493867 @default.

• next